[Interpretable machine learning models for preoperative precision prediction of perineural invasion in cervical cancer to support treatment decision: a multicenter retrospective study].

Authors

Mengxin Zhu, Xiao Liu, Shan Zhao, Xin Zhang, Chao Liu, Xiankong Liu, Haochen Qi, Tiesheng Han, Dong Ma

Published in

Nan fang yi ke da xue xue bao = Journal of Southern Medical University. Volume 46. Issue 7. Pages 1509-1519. Jul 20, 2026.

Abstract

To develop an interpretable machine learning model and web-based prediction tool for preoperative risk assessment of perineural invasion (PNI) in cervical cancer.
A total of 845 cervical cancer patients undergoing radical surgery at Fourth Hospital of Hebei Medical University were retrospectively enrolled and divided into training and testing sets in a 7:3 ratio, with another 223 cervical cancer patients at Hebei Medical University Second Hospital during the same period serving as the external validation cohort. LASSO regression identified 13 preoperative predictors, which were incorporated into 7 machine learning algorithms. Model performance was evaluated using AUC and decision curve analysis. The optimal model was interpreted using SHAP values and deployed as a web-based prediction tool.
Of the total of 1068 patients enrolled, 192 (17.98%) were diagnosed to have PNI. Thirteen preoperative features, namely lymphovascular space invasion (LVSI), depth of stromal invasion, lymph node metastasis (LNM), colposcopy-directed biopsy (CDB), tumor maximum diameter, carcinoembryonic antigen, SCC-Ag, platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-albumin-neutrophil ratio (LANR), menopausal status, age, and histological type were selected. Comparison of model performance revealed that the Extreme Gradient Boosting (XGBoost) model resulted in the best efficacy in both the training and testing datasets with AUC of 0.962 and 0.923 (95% CI: 0.942-0.979 and 0.874-0.960), sensitivity of 0.873 and 0.767, and specificity of 0.939 and 0.942, respectively. Decision curve analysis demonstrated greater net benefit of the XGBoost model across a broader threshold range. The SHAP-XGBoost model showed excellent performance in external validation with an AUC of 0.924 and an accuracy of 0.933.
The interpretable SHAP-XGBoost model effectively predicts PNI risk preoperatively. The predictive website derived from this model provides an useful tool to facilitate clinical decision-making in cervical cancer treatment.

PMID:
42486820
Bibliographic data and abstract were imported from PubMed on 23 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.